These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 21839242

  • 1. Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.
    Casanovas T, Argudo A, Peña-Cala MC.
    Transplant Proc; 2011; 43(6):2233-6. PubMed ID: 21839242
    [Abstract] [Full Text] [Related]

  • 2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 3. Everolimus in clinical practice in long-term liver transplantation: an observational study.
    Casanovas T, Argudo A, Peña-Cala MC.
    Transplant Proc; 2011 Feb; 43(6):2216-9. PubMed ID: 21839237
    [Abstract] [Full Text] [Related]

  • 4. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S, Hunt DR, Stone MA, McClune A, Tong MJ.
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [Abstract] [Full Text] [Related]

  • 5. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD, Te HS, Thomas RM, Hussain H, Bond K, Black M.
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [Abstract] [Full Text] [Related]

  • 6. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB, Belli LS, Airoldi A, de Carlis L, Rondinara G, Minola E, Vangeli M, Cernuschi A, D'Amico M, Forti D, Pinzello G.
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [Abstract] [Full Text] [Related]

  • 7. [Autoimmune hepatitis: clinical forms and related factors to their response to treatment].
    Dávalos M, Román R, Bustios C, Zumaeta E, Yabar A.
    Rev Gastroenterol Peru; 2004 Oct; 24(4):305-13. PubMed ID: 15614298
    [Abstract] [Full Text] [Related]

  • 8. De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report.
    Zhang Y, Wang B, Wang T.
    Transplant Proc; 2010 Nov; 42(9):3854-7. PubMed ID: 21094869
    [Abstract] [Full Text] [Related]

  • 9. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 10. Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
    Zhao XY, Rakhda MI, Wang TI, Jia JD.
    Transplant Proc; 2013 Mar; 45(2):824-7. PubMed ID: 23498828
    [Abstract] [Full Text] [Related]

  • 11. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH.
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [Abstract] [Full Text] [Related]

  • 12. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C.
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [Abstract] [Full Text] [Related]

  • 13. Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients.
    Lee WC, Wu TJ, Chou HS, Lee CF, Chan KM, Cheng SS.
    J Viral Hepat; 2010 Nov; 17(11):770-7. PubMed ID: 20337926
    [Abstract] [Full Text] [Related]

  • 14. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
    Berardi S, Lodato F, Gramenzi A, D'Errico A, Lenzi M, Bontadini A, Morelli MC, Tamè MR, Piscaglia F, Biselli M, Sama C, Mazzella G, Pinna AD, Grazi G, Bernardi M, Andreone P.
    Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
    [Abstract] [Full Text] [Related]

  • 15. De novo autoimmune hepatitis after liver transplantation.
    Guido M, Burra P.
    Semin Liver Dis; 2011 Feb; 31(1):71-81. PubMed ID: 21344352
    [Abstract] [Full Text] [Related]

  • 16. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T, Tanaka S, Uenishi T, Kanazawa A, Kubo S, Hirohashi K.
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [Abstract] [Full Text] [Related]

  • 17. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Dec; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 18. De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution's experience.
    Cho JM, Kim KM, Oh SH, Lee YJ, Rhee KW, Yu E.
    Transplant Proc; 2011 Dec; 43(6):2394-6. PubMed ID: 21839275
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.
    Fernandes NF, Redeker AG, Vierling JM, Villamil FG, Fong TL.
    Am J Gastroenterol; 1999 Jan; 94(1):241-8. PubMed ID: 9934764
    [Abstract] [Full Text] [Related]

  • 20. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J.
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.